Clinical Trials Logo

Cancer: Breakthrough Pain clinical trials

View clinical trials related to Cancer: Breakthrough Pain.

Filter by:
  • None
  • Page 1

NCT ID: NCT02591017 Terminated - Clinical trials for Cancer: Extreme Pain on Movement

Comparison of Oral Morphine Versus Nasal Ketamine Spray With Chitosan in Cancer Pain Outpatients

ONKEMI
Start date: February 2015
Phase: Phase 3
Study type: Interventional

34 adult (>18 years) cancer pain outpatients with Opioid base therapy because of pain and breakthrough pain or extreme pain on movement will be included in this prospective, randomized, double-blind crossover study. Over a period of 3 weeks patients will go through 3 treatment arms, each one lasting one week: Group A receives morphine drops and Placebo spray, Group B receives ketamine/chitosan spray nasal and Placebo drops and Group C receives morphine drops and ketamine/chitosan spray nasal. Primary endpoint is time to onset of action of intranasal ketamine compared with morphine drops. Secondary endpoint is the median numeric rating scale (NRS) improvement after using the spray or morphine or the combination of ketamine spray and morphine drops.